Clopidogrel and rhabdomyolysis after heart transplantation

Journal of Heart and Lung Transplantation

Volumn 22, Issue 1, 2003, Pages 107-108

  Uber, Patricia A ^a   Mehra, Mandeep R ^a   Park, Myung H ^a   Scott, Robert L ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; AZATHIOPRINE; CLONIDINE; CLOPIDOGREL; CREATINE KINASE; CYCLOSPORIN; CYTOCHROME P450 1A; CYTOCHROME P450 2C9; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LISINOPRIL; MEVINOLIN; PREDNISOLONE; SIMVASTATIN;

ACUTE KIDNEY FAILURE; ADULT; CASE REPORT; CORONARY ARTERY OBSTRUCTION; HEART TRANSPLANTATION; HUMAN; HYDRATION; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOPROPHYLAXIS; ISCHEMIC HEART DISEASE; LETTER; MALE; MUSCLE WEAKNESS; MYALGIA; PRIORITY JOURNAL; RHABDOMYOLYSIS; STENT; THROMBOCYTE AGGREGATION; THROMBOSIS;

DRUG INTERACTIONS; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RHABDOMYOLYSIS; TICLOPIDINE;

EID: 0037229601     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(02)00479-5     Document Type: Letter

References (6)

1. Rodriguez J.A., Crespo-Leiro M.G., Paniagua M.J., et al. Rhabdomyolysis in heart transplant patients on HMG-CoA reductase inhibitors and cyclosporine. Transplant Proc. 31:1999;2522-2523.
2. Bertrand M.E., Rupprecht H.J., Urban P., Gershlick A.H. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting the clopidogrel aspirin stent international cooperative study (CLASSICS) . Circulation. 102:2000;624-629.
3. Savi P., Combalbert J., Gaich C., et al. The antiaggregating activity of clopidogrel is due to a metabolic activation by the hepatic cytochrome P450-1A. Thromb Haemost. 72:1994;313-317.
4. Mehta S.R., Yusuf S., Peters R.J., et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention the PCI-CURE study . Lancet. 358:2001;527-533.
5. Jain S.P., Ramee S.R., White C.J., et al. Coronary stenting in cardiac allograft vasculopathy. J Am Coll Cardiol. 32:1998;1636-1640.
6. Cohen L.H., van Leeuwen R.E., van Thiel G.C., van Pelt J.F., Yap S.H. Equally potent inhibitors of cholesterol synthesis in human hepatocytes have distinguishable effects on different cytochrome P450 enzymes. Biopharm Drug Dispos. 21:2000;353-364.